Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H28N2O |
Molecular Weight | 348.4812 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCCC[C@H]1CCC2=CC=CC=C2NC(=O)\C=C\C3=CC=CC=C3
InChI
InChIKey=UXIPFQUBOVWAQW-UEBLJOKOSA-N
InChI=1S/C23H28N2O/c1-25-18-8-7-12-21(25)16-15-20-11-5-6-13-22(20)24-23(26)17-14-19-9-3-2-4-10-19/h2-6,9-11,13-14,17,21H,7-8,12,15-16,18H2,1H3,(H,24,26)/b17-14+/t21-/m0/s1
Molecular Formula | C23H28N2O |
Molecular Weight | 348.4812 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01355874
Intra-Anal Application of Iferanserin (10 mg) as a 0.5% Ointment
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:50:31 GMT 2023
by
admin
on
Sat Dec 16 17:50:31 GMT 2023
|
Record UNII |
NWR3BEB8PA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
315910
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
||
|
NCI_THESAURUS |
C66885
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6445539
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY | |||
|
300000036998
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107754
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY | |||
|
DB11686
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY | |||
|
C90945
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY | |||
|
58754-46-4
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
NWR3BEB8PA
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY | |||
|
8334
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY | |||
|
951155-17-2
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY | |||
|
C572904
Created by
admin on Sat Dec 16 17:50:31 GMT 2023 , Edited by admin on Sat Dec 16 17:50:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|